ITRM

Iterum Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Iterum Therapeutics PLC ITRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0035 -0.42% 0.8375 19:59:18
Open Price Low Price High Price Close Price Previous Close
0.80 0.78 0.8773 0.8425 0.841
more quote information »

Recent News

Date Time Source Heading
12/02/202016:32EDGARStatement of Ownership (sc 13g)
11/30/202009:15GLOBEIterum Therapeutics Submits New Drug Application to U.S...
11/23/202017:02EDGARInitial Statement of Beneficial Ownership (3)
11/16/202007:20EDGARQuarterly Report (10-q)
11/16/202006:45GLOBEIterum Therapeutics Reports Third Quarter 2020 Financial..
10/29/202013:01EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/28/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
10/27/202017:29EDGARCurrent Report Filing (8-k)
10/26/202017:28EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
10/23/202000:02GLOBEIterum Therapeutics Announces Pricing of $17.5 Million..
10/22/202008:20EDGARSecurities Registration Statement (s-1/a)
10/19/202019:09GLOBEUPDATE -- Iterum Therapeutics to Present Data from Phase 3..
10/19/202018:00GLOBEIterum Therapeutics to Present Data from Phase 3 Trials in..
10/09/202017:27EDGARSecurities Registration Statement (s-1)
10/05/202008:54EDGARSecurities Registration Statement (s-1/a)
9/30/202007:00GLOBEIterum Therapeutics Announces Positive Pre-NDA Meeting with..
9/25/202016:16EDGARCurrent Report Filing (8-k)
9/22/202006:02EDGARSecurities Registration Statement (s-1)
9/08/202016:30GLOBEIterum Therapeutics to Present at the 22nd Annual H.C...
9/02/202007:16EDGARAmended Current Report Filing (8-k/a)
9/02/202007:00GLOBEIterum Therapeutics Announces Revised Results of Rights..
9/01/202016:06EDGARCurrent Report Filing (8-k)
8/31/202020:00GLOBEIterum Therapeutics Announces Expiration and Preliminary..
8/27/202008:18EDGARProspectus Filed Pursuant to Rule 424(b)(1) (424b1)
8/13/202016:25EDGARSecurities Registration Statement (s-1)
8/13/202016:17EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/11/202008:38EDGARCurrent Report Filing (8-k)
8/11/202008:21EDGARProspectus Filed Pursuant to Rule 424(b)(1) (424b1)
8/11/202008:00GLOBEIterum Therapeutics Commences Rights Offering
8/06/202017:30EDGARSecurities Registration Statement (s-1/a)
8/06/202008:05EDGARAmended Quarterly Report (10-q/a)
8/06/202007:17EDGARQuarterly Report (10-q)
8/06/202006:45GLOBEIterum Therapeutics Reports Second Quarter 2020 Financial..
7/17/202016:05EDGARCurrent Report Filing (8-k)
7/13/202016:31EDGARCurrent Report Filing (8-k)
7/13/202016:05GLOBEIterum Therapeutics Informs Shareholders of Record Date for..
7/10/202016:20EDGARStatement of Ownership (sc 13g)
7/06/202014:37EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/06/202006:30EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202018:27EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202016:25EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202006:33EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/01/202006:32EDGARCurrent Report Filing (8-k)
6/30/202009:12GLOBEIterum Therapeutics Announces $5 Million Registered Direct..
6/29/202007:45EDGARCurrent Report Filing (8-k)
6/29/202007:30GLOBEIterum Therapeutics Announces Topline Results from its Phase..
6/16/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202016:46EDGARCurrent Report Filing (8-k)
6/15/202016:30GLOBEIterum Therapeutics plc Announces Result of Proposal 8 at..
6/12/202018:00EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NASDAQ
ITRM
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201205 12:54:27